Dual mechanisms underlie the repression of REST expression in lung neuroendocrine carcinoma cells
Open Access
- 18 June 2026
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (9) , 1839-1854
Abstract
No abstract availableKeywords
Funding Information
- Dokkyo Medical University
- Japan Society for the Promotion of Science
This publication has 39 references indexed in Scilit:
- Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiationCancer Cell, 2023
- REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine CarcinomaThe American Journal of Pathology, 2022
- In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinomaInternational Journal of Cancer, 2021
- ASCL1, NKX2-1, and PROX1 co-regulate subtype-specific genes in small-cell lung canceriScience, 2021
- MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine FateCancer Cell, 2020
- Plasticity in the Adult: How Should the Waddington Diagram Be Applied to Regenerating Tissues?Developmental Cell, 2016
- REST and Its Corepressors Mediate Plasticity of Neuronal Gene Chromatin throughout NeurogenesisCell, 2005
- Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancerThe Journal of Pathology, 1999
- Small cell lung carcinoma: Clinicopathological, immunohistochemical, and ultrastructural studyJournal of Surgical Oncology, 1990
- Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lungThe Journal of Pathology, 1987